Nabriva Therapeutics plc Long-Term Debt
Nabriva Therapeutics plc had Long-Term Debt of $344.00 thousand as of 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2023-10-19
- 2023-06-30: Long-term Debt, Excluding Current Maturities $344.00K.
- 2023-03-31: Long-term Debt, Excluding Current Maturities $345.00K.
- 2022-12-31: Long-term Debt, Excluding Current Maturities $388.00K.
- 2022-09-30: Long-term Debt, Excluding Current Maturities $399.00K.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2023-06-30 | $344.00K 10-Q · filed 2023-10-19 |
| 2023-03-31 | $345.00K 10-Q · filed 2023-05-22 |
| 2022-12-31 | $388.00K 10-Q · filed 2023-10-19 |
| 2022-09-30 | $399.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $512.00K 10-Q · filed 2022-08-03 |
| 2022-03-31 | $3.92M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $4.26M 10-K · filed 2023-04-17 |
| 2021-09-30 | $5.17M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $6.05M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $5.18M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $5.69M 10-K · filed 2022-03-29 |
| 2020-09-30 | $7.61M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $7.48M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $7.37M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $34.50M 10-K · filed 2021-03-11 |
| 2019-09-30 | $34.24M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $24.31M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $23.95M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $23.72M 10-K · filed 2020-03-12 |
| 2018-09-30 | $710.00K 10-Q · filed 2018-11-06 |
| 2018-06-30 | $592.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $411.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $232.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $227.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $218.00K 10-Q · filed 2017-08-07 |
| 2017-03-31 | $203.00K 10-Q · filed 2017-05-10 |